XML 40 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Collaboration, License and Research Agreements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Collaboration License And Research Agreements [Abstract] |
Summary of Reconciliation of Deferred Revenue Related to Lilly Agreement | A reconciliation of the closing balance of deferred revenue related to the Lilly Agreement is as follows (in thousands):
Balance at December 31, 2019 |  | $ | 18,940 |
Revenue recognized |  |  | (3,100 | )
Balance at December 31, 2020 |  |  | 15,840 |
Revenue recognized |  |  | (4,732 | )
Balance at December 31, 2021 |  | $ | 11,108 |

X
- Definition Collaboration, license and research agreements. + References No definition available. + Details
Name: | rna_CollaborationLicenseAndResearchAgreementsAbstract
Namespace Prefix: | rna_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration